A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy
Status:
Completed
Trial end date:
2017-07-11
Target enrollment:
Participant gender:
Summary
The goal of this study with SCB01A is to determine the Maximum Tolerated Dose of SCB01A in
patients with advanced solid tumors that have failed previous therapy.